
Occlutech AFR (ATRIAL FLOW REGULATOR) - Occlutech - Every …
The Atrial Flow Regulator (AFR) is an innovative cardiac implant which is designed to address the unmet medical needs of patients suffering from heart failure (HF) despite optimal medical therapy.
AFR Program Lineup
All shows are Central Standard Time. Wallbuilders Live! - David Barton.
Heart failure - AFR - Occlutech - Every beat counts
The AFR is a CE-marked EU Class III implantable, interatrial, shunting device dedicated to addressing shortcomings of atrial septostomy and improving overall safety and outcomes of interatrial shunting in patients with HFpEF or HFrEF.
AFR.net - Hannah's Heart
2025年3月1日 · Hannah’s Heart is a half hour program to encourage couples walking through infertility and miscarriage. It’s about clinging to Christ, the ultimate hope and finding peace and joy in the midst of the journey. Hosted by AFA’s very own Anne Cockrell and Kendra White.
Multi-Institutional US Experience of the Occlutech© AFR Device in ...
2021年10月25日 · The atrial flow regulator device (AFR) by Occlutech © was designed primarily to treat adult patients with symptomatic heart failure, with both preserved and reduced ejection fraction.
Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA …
2021年1月19日 · Reduced left atrial pressure has been shown to reduce heart failure symptoms and improve exercise tolerance. Breakthrough Device Designations aim to accelerate the...
Atrial Flow Regulator - Occlutech - Every beat counts
Left-sided heart failure is divided into heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF). Both are caused by changes in the walls of the heart’s chambers (ventricles) causing them to become weak and stiff. The result is that the heart becomes less efficient at pumping blood.
OneVentures-backed artificial heart start-up BiVACOR rattles the …
2025年3月16日 · BiVACOR has made the world’s first titanium heart and is hoping to manufacture the device commercially in Australia and the US within three years.
The AFR-PRELIEVE trial: a prospective, non-randomised, pilot …
2019年8月29日 · Aims: Reducing elevated left atrial pressure with an atrial septum shunt device is a possible treatment option in symptomatic heart failure patients. This study aimed to investigate the safety and feasibility of the Atrial Flow Regulator (AFR) in heart failure patients.
Atrial Flow Regulator for Postcapillary Pulmonary Hypertension:
Restrictive cardiomyopathy (RCM) has a poor prognosis and limited treatment options apart from heart transplantation (HTx). We report on the first-in-human interventional atrial flow regulator (AFR) implantations in 3 children with RCM, leading …